PIA
CORT icon

Piedmont Investment Advisors’s Corcept Therapeutics CORT Stock Holding History

Piedmont Investment Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,196
Closed -$308K – 1003
2019
Q1 		$308K Buy
26,196
+1,321
+5% +$16.4K 0.01% 791
2018
Q4 		$332K Buy
24,875
+677
+3% +$8.95K 0.02% 657
2018
Q3 		$339K Buy
24,198
+1,874
+8% +$26.2K 0.01% 725
2018
Q2 		$351K Buy
22,324
+1,953
+10% +$34K 0.02% 572
2018
Q1 		$335K Buy
20,371
+901
+5% +$16.7K 0.01% 530
2017
Q4 		$352K Buy
+19,470
New +$353K 0.01% 512

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Piedmont Investment Advisors's CORT Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Corcept Therapeutics (CORT) in Q2 2019, closing a stake of 26,196 shares — an estimated $308K sold.

Piedmont Investment Advisors first reported a position in CORT in Q4 2017 and held it in 6 quarters. The position peaked at $352K in Q4 2017. 183 funds tracked by Wall St. Rank hold CORT as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Corcept Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 26,196 Corcept Therapeutics shares in Q2 2019, an estimated $308K.
  • Piedmont Investment Advisors first reported a position in Corcept Therapeutics in Q4 2017 and held it in 6 quarters.
  • Piedmont Investment Advisors's Corcept Therapeutics position peaked at $352K in Q4 2017.
  • 183 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.